Home
Conditions
Muscular Atrophy, Spinal

Clinical trial condition

Muscular Atrophy, Spinal

Explore clinical trials studying Muscular Atrophy, Spinal. Study availability and eligibility vary by location and protocol.

56 public trials 13 recruiting studies

Refine in advanced search Browse all conditions

Muscular Atrophy, Spinal trial results

Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

NCT01793168

Conditions: 1p36 Deletion Syndrome, 3-Methylglutaconic Aciduria, Type V, 4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome, +698 more
Locations: Sanford Health Sioux Falls, South Dakota, United States

Online Patient Enrollment System Sydney, Australia

View Trial Details

Recruiting

Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy

NCT06862596

Conditions: Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations: Tokyo University Hospital Bunkyō City, Japan

Chiba University Hospital Chiba, Japan

Hokkaido University Hospital Sapporo, Japan

Jichi Medical University Hospital Shimotsuke, Japan

View Trial Details

Recruiting

A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy

NCT06169046

Conditions: Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations: Azienda Ospedale Università di Padova Padova, PD, Italy

View Trial Details

Enrolling by Invitation

GCB-001 in Treatment of Patients With Type II (SMA) Spinal Muscular Atrophy

NCT06772402

Conditions: Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations: Children's Hospital ZheJiang Univisity School Of Medicine Hangzhou, Zhejiang, China

View Trial Details

Enrolling by Invitation

Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients with Spinal Muscular Atrophy Type 1

NCT05614531

Conditions: Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations: The Children's Hospital of Fudan University Shanghai, Shanghai Municipality, China

The Children'S Hospital Zhejiang University of Medicine Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I

NCT07554924

Conditions: Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

Children's Hospital of Fudan University Shanghai, Shanghai Municipality, China

Children's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Exploring Lived Experiences of Families of Children With Spinal Muscular Atrophy(SMA) Type 1 Regarding Feeding and Communication

NCT07596277

Conditions: Behavior, Central Nervous System Diseases, Communication, +20 more
Locations: GSTT Evelina Neurosciences London, United Kingdom

View Trial Details

Completed

Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"

NCT03555578

Conditions: Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations: Takeda Selected Site Tokyo, Japan

View Trial Details

Completed

Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)

NCT05694819

Conditions: Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations: Nagoya University Hospital Nagoya, Aichi-ken, Japan

Chiba University Hospital Chiba, Japan

National Cancer Center Hospital East Kashiwa, Chiba, Japan

National Hospital Organization Kyushu Medical Center Fukuoka, Japan

View Trial Details

Completed

A Study of NIDO-361 in Patients With SBMA

NCT06411912

Conditions: Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations: Rigshospitalet, Klinik for Nerve- og Muskelsygdomme & Copenhagen Neuromuscular Center Copenhagen, Denmark

IRCCS Istituto Neurologico Carlo Besta Milan, Italy

Azienda Ospedale Università di Padova Padova, Italy

Kyungpook National University Chilgok Hospital Daegu, South Korea

View Trial Details

Muscular Atrophy, Spinal

Muscular Atrophy, Spinal trial results

Related conditions